SCHEMBL6421558

SCHEMBL6421558

O=C(Nc1ncnc2c1nnn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 6/20 0.50
▸ ADK P55263 6/20 0.50
▸ LMNA P02545 2/20 0.50
▸ SLC29A1 Q99808 2/20 0.50
▸ ADA P00813 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ GLA P06280 1/20 0.50
▸ PMP22 Q01453 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ NPY1R P25929 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ NPY2R P49146 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ RXFP1 Q9HBX9 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ NFKB1 P19838 1/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24687189 1.00 ADORA1 (0.50) ADORA1ADKLMNASLC29A1ADA
SCHEMBL18490487 0.92 ADORA1 (0.45) ADORA1ADKLMNASLC29A1ALDH1A1
SCHEMBL18522117 0.87 ALDH1A1 (0.42) ADORA1ADKLMNASLC29A1ALDH1A1
SCHEMBL13396431 0.84 PI4KA (0.45) ADORA1SLC29A1ADORA3ADORA2AADORA2B
SCHEMBL3314735 0.84 PI4KA (0.45) ADORA1SLC29A1ADORA3ADORA2AADORA2B
SCHEMBL17301042 0.83 LMNA (0.72) ADORA1LMNASLC29A1ALDH1A1GLA
SCHEMBL17889837 0.83 LMNA (0.72) ADORA1LMNASLC29A1ALDH1A1GLA
SCHEMBL21953578 0.83 LMNA (0.72) ADORA1LMNASLC29A1ALDH1A1GLA
SCHEMBL6909853 0.83 LMNA (0.72) ADORA1LMNASLC29A1ALDH1A1GLA
SCHEMBL233209 0.83 LMNA (0.72) ADORA1LMNASLC29A1ALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018198084-A1 CYCLIC DI-NUCLEOTIDE COMPOUNDS WITH TRICYCLIC NUCLEOBASES LUPIN LIMITED (IN) 2018-11-01 — — WO disclosed
EP-1589028-A2 Modified oligonucleotides, their preparation and their use Aventis Pharma Deutschland GmbH (DE) 2005-10-26 — — EP disclosed
EP-0680969-B1 Modified oligonucleotides, their preparation and their use AVENTIS PHARMA GMBH (DE) 2005-07-27 — — EP disclosed
US-6066720-A WITH AT LEAST ONE 8-AZAPURINE BASE; FORMS MORE STABLE HYBRIDIZATION COMPLEXES WITH NUCLEIC ACIDS; FOR ANTISENSE AGENTS, DIAGNOSTIC AGENTS, PROBES, PRIMERS HOECHST AKTIENGESELLSCHAFT (DE) 2000-05-23 — — US disclosed
EP-0680969-A2 Modified oligonucleotides, their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1995-11-08 — — EP disclosed
Send feedback